Price movement over the last 24 hours
Bio Protocol vs Huma Finance — how do they compare? Bio Protocol trades at Rp522.6 (market cap Rp1,17T, Rp248,44M 24h volume), while Huma Finance trades at Rp398.38 (market cap Rp1,3T, Rp131,14M 24h volume). The key difference: Bio Protocol and Huma Finance are close in size by market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 3,3B / 10B HUMA (33%) for Huma Finance. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Huma Finance for 13 Days on average.
| BIO | HUMA | |
|---|---|---|
Market Cap | Rp1,17T | Rp1,3T |
Volume (24h) | Rp248,44M | Rp131,14M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 3,3B / 10B HUMA (33%) |
Typical Hold Time | 16 Days | 13 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp521.46 with a market cap of Rp1.16T, showing bearish technical signals as moving averages indicate selling pressure while oscillators remain neutral. The token's circulating supply of 2.2M out of 3.3M max supply (68% circulation) suggests controlled token distribution. Current price sits near the pivot point of Rp521 with immediate support at Rp508 and resistance at Rp530. Recent market activity shows average hold time of 16 days, indicating relatively short-term trading patterns in the current bearish environment.
Overall outlook remains cautious with technical indicators favoring sellers, though oversold RSI conditions may present short-term bounce opportunities. Key risks include continued bearish momentum and low trading volumes, while potential upside could come from any positive ecosystem developments or market-wide crypto recovery. Investors should monitor support levels closely for entry points.
Huma Finance (HUMA) is trading at Rp409.59 with a market cap of Rp1.34 trillion, showing bullish technical signals with 12 buy indicators versus 5 sell. The token maintains neutral oscillators but strong moving average support. Current price sits near the pivot point of Rp410, with immediate resistance at Rp421 and support at Rp401. With only 33% of the 10 million max supply in circulation and an average hold time of 13 days, the token exhibits controlled distribution.
Overall outlook remains cautiously optimistic with technical strength but limited fundamental developments. Key opportunities include potential breakout above Rp421 resistance, while risks involve low circulation rate impacting liquidity and typical crypto volatility. Investors should monitor trading volume patterns and broader market sentiment for directional cues.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Huma Finance is the first PayFi network that provides global payment financing with instant, on-demand liquidity—available anytime and anywhere. It enables payment institutions around the world to settle transactions 24/7 using stablecoins and on-chain liquidity. Huma supports a wide variety of PayFi use cases, including cross-border payments, credit card settlements, and trade finance, while also facilitating emerging solutions such as decentralized physical infrastructure network (DePIN) financing.
Read more on HUMA →